Hyowon Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hyowon Lee has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Hyung Joo Suh
Department of Integrated Biomedical and Life Science, Graduate School, Korea University, Seoul 02841, Republic of Korea
6 shared publications Seok Hyun Chung
5 shared publicationsHyeongyeong Kim
Department of Integrated Biomedical and Life Science, Graduate School University of Korea Seoul Republic of Korea
4 shared publications- Hyeon-Son Choi
Department of Food Nutrition, Sangmyung University, Seoul, Republic of Korea
3 shared publications - Jungil Hong
Department of Food Science and Technology, College of Science and Convergence Technology, Seoul Women’s University, Hwarang-ro 621, Nowon-gu, Seoul 01797, Republic of Korea
2 shared publications Singeun Kim
Life Science Research Institute, NOVAREX Co., Ltd Cheongju Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 23 November 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 106 (4) , 2100-2110
Chrysanthemum morifolium extract protects HT22 cells from oxidative stress and enhances sleep via GABAergic modulation: contribution of luteolin‐7‐glucoside
BACKGROUND: Chrysanthemum morifolium has long been utilized in traditional medicine for its antioxidant and sedative properties, yet its potential in sleep regulation and neuroprotection against oxidative stress remains underexplored. This study investigates the antioxidant and sleep‐enhancing effects of C. morifolium extract (CE) in HT22 hippocampal neuronal cells and animal models, focusing on its bioactive component, luteolin‐7‐glucoside (L‐7‐G) and the underlying molecular mechanisms. RESULTS: CE exhibited potent antioxidant activity, significantly reducing reactive oxygen species and malondialdehyde levels while improving cell survival under oxidative stress. It upregulated antioxidant enzyme expression and activated the Nrf2/HO‐1 pathway, effects linked to L‐7‐G. In pentobarbital‐induced sleep models, CE increased sleep duration by up to 1.41‐fold compared to controls, with L‐7‐G showing similar efficacy. Electroencephalography revealed enhanced δ‐wave activity and prolonged non‐rapid eye movement (NREM) sleep with CE treatment. In a caffeine‐induced insomnia model, CE reduced wake time, restored NREM sleep, and counteracted sleep disturbances by enhancing δ‐wave activity. Mechanistic analysis showed CE upregulated GABA A and 5‐HT 1A receptor expression, with its sleep‐promoting effects partially mediated through GABA A receptor interactions. CONCLUSION: CE, particularly through L‐7‐G, exhibits significant potential as a natural agent for reducing oxidative stress and enhancing sleep quality, offering a promising avenue for managing sleep disorders. © 2025 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
- 23 November 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 106 (4) , 2100-2110
Open AccessChrysanthemum morifolium extract protects HT22 cells from oxidative stress and enhances sleep via GABAergic modulation: contribution of luteolin‐7‐glucoside
BACKGROUND: Chrysanthemum morifolium has long been utilized in traditional medicine for its antioxidant and sedative properties, yet its potential in sleep regulation and neuroprotection against oxidative stress remains underexplored. This study investigates the antioxidant and sleep‐enhancing effects of C. morifolium extract (CE) in HT22 hippocampal neuronal cells and animal models, focusing on its bioactive component, luteolin‐7‐glucoside (L‐7‐G) and the underlying molecular mechanisms. RESULTS: CE exhibited potent antioxidant activity, significantly reducing reactive oxygen species and malondialdehyde levels while improving cell survival under oxidative stress. It upregulated antioxidant enzyme expression and activated the Nrf2/HO‐1 pathway, effects linked to L‐7‐G. In pentobarbital‐induced sleep models, CE increased sleep duration by up to 1.41‐fold compared to controls, with L‐7‐G showing similar efficacy. Electroencephalography revealed enhanced δ‐wave activity and prolonged non‐rapid eye movement (NREM) sleep with CE treatment. In a caffeine‐induced insomnia model, CE reduced wake time, restored NREM sleep, and counteracted sleep disturbances by enhancing δ‐wave activity. Mechanistic analysis showed CE upregulated GABA A and 5‐HT 1A receptor expression, with its sleep‐promoting effects partially mediated through GABA A receptor interactions. CONCLUSION: CE, particularly through L‐7‐G, exhibits significant potential as a natural agent for reducing oxidative stress and enhancing sleep quality, offering a promising avenue for managing sleep disorders. © 2025 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
- Open Access
- 5 November 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (23) , 9174-9190
Standardized fenugreek seed extract alleviates menopausal sleep disturbances via GABAA, melatonin, and adenosine receptors in ovariectomized (OVX) rodents
Fenugreek seed extract rich in trigonelline, protodioscin, and 4-hydroxy- l -isoleucine alleviates menopause-related sleep disturbances in OVX mice by modulating GABAergic, melatoninergic, and adenosinergic pathways.
- 5 November 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (23) , 9174-9190
Open AccessStandardized fenugreek seed extract alleviates menopausal sleep disturbances via GABAA, melatonin, and adenosine receptors in ovariectomized (OVX) rodents
Fenugreek seed extract rich in trigonelline, protodioscin, and 4-hydroxy- l -isoleucine alleviates menopause-related sleep disturbances in OVX mice by modulating GABAergic, melatoninergic, and adenosinergic pathways.
- Open Access
- 17 September 2025
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 33 (3) , 291-301
Protective effects of jujube seed extract against oxidative stress in HT22 cells and its sleep-promoting action through GABAergic receptors
Jujube seed extract (JSE), rich in polyphenols and flavonoids, exhibits neuroprotective and sleep-enhancing properties.In vitro, JSE protected HT22 cells against oxidative stress by activating the Nrf2/HO-1 pathway and upregulatingantioxidant enzymes. In vivo, JSE increased non-REM sleep and delta wave activity in pentobarbital- and caffeine-induced sleep models. Spinosin contributed to these effects. Long-term JSE administration upregulated GABAA, GABAB, and 5-HT1A receptors in brain tissue. These findings suggest that JSE offers dual benefits in mitigating oxidativestress and promoting sleep through antioxidant defense and neurotransmitter modulation, supporting its potential as a natural therapeutic agent.
- 17 September 2025
- Published by The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA) in Journal of Food and Drug Analysis
- Vol. 33 (3) , 291-301
Open AccessProtective effects of jujube seed extract against oxidative stress in HT22 cells and its sleep-promoting action through GABAergic receptors
Jujube seed extract (JSE), rich in polyphenols and flavonoids, exhibits neuroprotective and sleep-enhancing properties.In vitro, JSE protected HT22 cells against oxidative stress by activating the Nrf2/HO-1 pathway and upregulatingantioxidant enzymes. In vivo, JSE increased non-REM sleep and delta wave activity in pentobarbital- and caffeine-induced sleep models. Spinosin contributed to these effects. Long-term JSE administration upregulated GABAA, GABAB, and 5-HT1A receptors in brain tissue. These findings suggest that JSE offers dual benefits in mitigating oxidativestress and promoting sleep through antioxidant defense and neurotransmitter modulation, supporting its potential as a natural therapeutic agent.
- Open Access
- 30 June 2025
- Published by Korean Society for Lactic Acid Bacteria and Probiotics in Current Topic in Lactic Acid Bacteria and Probiotics
- Vol. 11 (1) , 30-39
Anti-Obesity Effects of Lactococcus lactis JNU534 via AMPK Activation and Inhibition of Lipogenesis in 3T3-L1 Adipocytes
Current Topics in Lactic Acid Bacteria and Probiotics, 한국유산균프로바이오틱스학회 학술지
- 30 June 2025
- Published by Korean Society for Lactic Acid Bacteria and Probiotics in Current Topic in Lactic Acid Bacteria and Probiotics
- Vol. 11 (1) , 30-39
Open AccessAnti-Obesity Effects of Lactococcus lactis JNU534 via AMPK Activation and Inhibition of Lipogenesis in 3T3-L1 Adipocytes
Current Topics in Lactic Acid Bacteria and Probiotics, 한국유산균프로바이오틱스학회 학술지
- 6 February 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (8) , 4297-4305
Sleep‐enhancing activity of fermented pea protein hydrolysate with enhanced GABA content by Lactobacillus brevisSYLB 0016 fermentation
BACKGROUND: Sleep is essential for overall health and wellbeing. This study investigated the sleep‐promoting effects of fermented pea protein hydrolysate (PPF) with increased gamma‐aminobutyric acid (GABA) content produced by Lactobacillus brevis SYLB 0016. The effects of PPF on sleep duration and structure were assessed in pentobarbital‐induced ICR mice and Sprague Dawley (SD) rats using electroencephalogram (EEG) analysis.RESULTS: Hydrolysis of pea protein with Alcalase, Protana Prime, and Protana UBoost increased the amino nitrogen content, degree of hydrolysis and glutamate content to 160.51 mmol L−1. Fermentation by Lactobacillus brevis SYLB 0016 increased the GABA content from 3.16 to 90.35 mmol L−1. PPF significantly increased sleep duration (56.3 min) compared to the normal control (30.6 min) in pentobarbital‐induced sleep tests. Non‐rapid eye movement (NREM) sleep time increased with a significant rise in δ‐waves activity following administration of 150 mg kg−1 of PPF. In caffeine‐induced insomnia, both low‐ and high‐dose PPF significantly increased sleep duration. Three weeks of oral PPF administration elevated GABAA and GABAB receptor expression, with GABAA receptor protein levels showing a significant change. Co‐administration of flumazenil with PPF reduced sleep time, indicating the involvement of the GABAA receptor benzodiazepine site in PPF's sleep‐enhancing effects.CONCLUSION: In conclusion, PPF with enhanced GABA content improves NREM sleep by increasing δ waves activity. As a hypoallergenic compound, PPF holds potential as a supplement to ameliorate sleep disorders. © 2025 Society of Chemical Industry.
- 6 February 2025
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 105 (8) , 4297-4305
Sleep‐enhancing activity of fermented pea protein hydrolysate with enhanced GABA content by Lactobacillus brevisSYLB 0016 fermentation
BACKGROUND: Sleep is essential for overall health and wellbeing. This study investigated the sleep‐promoting effects of fermented pea protein hydrolysate (PPF) with increased gamma‐aminobutyric acid (GABA) content produced by Lactobacillus brevis SYLB 0016. The effects of PPF on sleep duration and structure were assessed in pentobarbital‐induced ICR mice and Sprague Dawley (SD) rats using electroencephalogram (EEG) analysis.RESULTS: Hydrolysis of pea protein with Alcalase, Protana Prime, and Protana UBoost increased the amino nitrogen content, degree of hydrolysis and glutamate content to 160.51 mmol L−1. Fermentation by Lactobacillus brevis SYLB 0016 increased the GABA content from 3.16 to 90.35 mmol L−1. PPF significantly increased sleep duration (56.3 min) compared to the normal control (30.6 min) in pentobarbital‐induced sleep tests. Non‐rapid eye movement (NREM) sleep time increased with a significant rise in δ‐waves activity following administration of 150 mg kg−1 of PPF. In caffeine‐induced insomnia, both low‐ and high‐dose PPF significantly increased sleep duration. Three weeks of oral PPF administration elevated GABAA and GABAB receptor expression, with GABAA receptor protein levels showing a significant change. Co‐administration of flumazenil with PPF reduced sleep time, indicating the involvement of the GABAA receptor benzodiazepine site in PPF's sleep‐enhancing effects.CONCLUSION: In conclusion, PPF with enhanced GABA content improves NREM sleep by increasing δ waves activity. As a hypoallergenic compound, PPF holds potential as a supplement to ameliorate sleep disorders. © 2025 Society of Chemical Industry.
- 9 November 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 338 (Pt 2) , 119019
Sleep-enhancing effect of Hongcheon-hop (Humulus lupulus L.) extract containing xanthohumol and humulone through GABAA receptor
- 9 November 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 338 (Pt 2) , 119019
Sleep-enhancing effect of Hongcheon-hop (Humulus lupulus L.) extract containing xanthohumol and humulone through GABAA receptor
- Open Access
- 1 November 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (11) , 8811-8823
Improvement of sleep duration and quality through GABAA receptor by whey protein hydrolysate containing DIQK as the main active compound
This study characterized the sleep activity, sleep mechanism, and active peptides of whey protein hydrolysates selected through behavioral analysis of fruit-flies (Drosophila melanogaster). Sleep-inducing whey protein (WP) hydrolysate was selected through fruit fly behavior analysis, and sleep activity was measured using a pentobarbital model and electroencephalographic analysis. The mechanism of action was confirmed using a γ-aminobutyric acid (GABA) receptor antagonist, and the active peptide was identified using liquid chromatography-mass spectroscopy. Whey protein hydrolysate, prepared using Alcalase and Prozyme (WP-AP), increased sleep time in a dose-dependent manner. WP-AP significantly increased not only sleep time but also slow-wave sleep and showed an insomnia-alleviating effect in a caffeine-induced insomnia mouse model. In addition, the gene and protein expression levels of GABA sub-type A (GABAA) receptors increased in the brains of mice orally administered with WP-AP. Through peptide analysis, the mixture of DIQK, VPPF peptide, and GABA contained in WP-AP was estimated to exhibit sleep activity, and due to its high content, DIQK was speculated to be the main sleep -inducing ingredient. These results indicate that WP-AP has the potential to be used as a new ingredient to improve sleep quality.
- 1 November 2024
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 107 (11) , 8811-8823
Open AccessImprovement of sleep duration and quality through GABAA receptor by whey protein hydrolysate containing DIQK as the main active compound
This study characterized the sleep activity, sleep mechanism, and active peptides of whey protein hydrolysates selected through behavioral analysis of fruit-flies (Drosophila melanogaster). Sleep-inducing whey protein (WP) hydrolysate was selected through fruit fly behavior analysis, and sleep activity was measured using a pentobarbital model and electroencephalographic analysis. The mechanism of action was confirmed using a γ-aminobutyric acid (GABA) receptor antagonist, and the active peptide was identified using liquid chromatography-mass spectroscopy. Whey protein hydrolysate, prepared using Alcalase and Prozyme (WP-AP), increased sleep time in a dose-dependent manner. WP-AP significantly increased not only sleep time but also slow-wave sleep and showed an insomnia-alleviating effect in a caffeine-induced insomnia mouse model. In addition, the gene and protein expression levels of GABA sub-type A (GABAA) receptors increased in the brains of mice orally administered with WP-AP. Through peptide analysis, the mixture of DIQK, VPPF peptide, and GABA contained in WP-AP was estimated to exhibit sleep activity, and due to its high content, DIQK was speculated to be the main sleep -inducing ingredient. These results indicate that WP-AP has the potential to be used as a new ingredient to improve sleep quality.
- Open Access
- 17 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 10016
Modulation of Photosensitizing Responses in Cell Culture Environments by Different Medium Components
Many cell culture experiments are performed under light to evaluate the photodynamic or photosensitizing efficacy of various agents. In this study, the modulation of photosensitizing responses and phototoxicity under cell culture conditions by different medium components was investigated. The significant levels of reactive oxygen species (ROS) generated from DMEM, RPMI 1640, and MEM were observed under the irradiation of fluorescent light (FL) and white and blue LEDs, indicating that these media have their own photosensitizing properties; DMEM showed the most potent property. Phenol red-free DMEM (Pf-D) exhibited a stronger photosensitizing property than normal DMEM by 1.31 and 1.25 times under FL and blue LEDs, respectively; phenol red and riboflavin-free DMEM (PRbf-D) did not show any photosensitizing properties. The inhibitory effect on light transmission was more pronounced in DMEM than in RPMI, and the interference effect on green LED light was greatest at 57.8 and 27.4%, respectively; the effect disappeared in Pf-D. The media containing riboflavin induced strong phototoxicity in HaCaT keratinocytes by generating H2O2 under light irradiation, which was quenched by sodium pyruvate in the media. The presence of serum in the media was also reduced the phototoxicity; H2O2 levels in the media decreased serum content dependently. The phototoxicity of erythrosine B and protoporphyrin IX under FL was more sensitively pronounced in PRbf-D than in DMEM. The present results indicate that several medium components, including riboflavin, phenol red, sodium pyruvate, and serum, could modulate photosensitizing responses in a cell culture system by inducing photosensitizing activation and by interfering with irradiation efficacy and ROS generation.
- 17 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (18) , 10016
Open AccessModulation of Photosensitizing Responses in Cell Culture Environments by Different Medium Components
Many cell culture experiments are performed under light to evaluate the photodynamic or photosensitizing efficacy of various agents. In this study, the modulation of photosensitizing responses and phototoxicity under cell culture conditions by different medium components was investigated. The significant levels of reactive oxygen species (ROS) generated from DMEM, RPMI 1640, and MEM were observed under the irradiation of fluorescent light (FL) and white and blue LEDs, indicating that these media have their own photosensitizing properties; DMEM showed the most potent property. Phenol red-free DMEM (Pf-D) exhibited a stronger photosensitizing property than normal DMEM by 1.31 and 1.25 times under FL and blue LEDs, respectively; phenol red and riboflavin-free DMEM (PRbf-D) did not show any photosensitizing properties. The inhibitory effect on light transmission was more pronounced in DMEM than in RPMI, and the interference effect on green LED light was greatest at 57.8 and 27.4%, respectively; the effect disappeared in Pf-D. The media containing riboflavin induced strong phototoxicity in HaCaT keratinocytes by generating H2O2 under light irradiation, which was quenched by sodium pyruvate in the media. The presence of serum in the media was also reduced the phototoxicity; H2O2 levels in the media decreased serum content dependently. The phototoxicity of erythrosine B and protoporphyrin IX under FL was more sensitively pronounced in PRbf-D than in DMEM. The present results indicate that several medium components, including riboflavin, phenol red, sodium pyruvate, and serum, could modulate photosensitizing responses in a cell culture system by inducing photosensitizing activation and by interfering with irradiation efficacy and ROS generation.
- Open Access
Lactobacillus brevis M2-Fermented Whey Protein Hydrolysate Increases Slow-Wave Sleep via GABAA Receptors in Rodent Models
In this study, we investigated the effects of whey protein hydrolysate (WPH) fermented with Lactobacillus brevis on sleep behavior and GABAergic mechanisms in rodent models. Fermentation converted the glutamate in WPH to high (3.15 ± 0.21 mg/mL) levels of γ-aminobutyric acid (GABA). Fermented WPH (WP-SF) enhanced sleep duration in mice by increasing GABA content in the brain. The increase in sleep duration induced by WP-SF resulted from an increase in delta wave activity during non-rapid eye movement sleep, and its sleep-promoting effect in a caffeine-induced insomnia model was characterized by an increase in delta waves. WP-SF increased GABAergic receptors at both mRNA and protein levels. Cotreatment with GABAA receptor antagonists abolished the sleep-promoting effects of WP-SF, indicating that WP-SF shares binding sites with antagonists on GABAA receptors. Collectively, WP-SF effectively increased sleep duration by enhancing delta wave activity through GABAergic activation; thus, it is suggested as a functional food-grade ingredient for promoting sleep.
Open AccessLactobacillus brevis M2-Fermented Whey Protein Hydrolysate Increases Slow-Wave Sleep via GABAA Receptors in Rodent Models
In this study, we investigated the effects of whey protein hydrolysate (WPH) fermented with Lactobacillus brevis on sleep behavior and GABAergic mechanisms in rodent models. Fermentation converted the glutamate in WPH to high (3.15 ± 0.21 mg/mL) levels of γ-aminobutyric acid (GABA). Fermented WPH (WP-SF) enhanced sleep duration in mice by increasing GABA content in the brain. The increase in sleep duration induced by WP-SF resulted from an increase in delta wave activity during non-rapid eye movement sleep, and its sleep-promoting effect in a caffeine-induced insomnia model was characterized by an increase in delta waves. WP-SF increased GABAergic receptors at both mRNA and protein levels. Cotreatment with GABAA receptor antagonists abolished the sleep-promoting effects of WP-SF, indicating that WP-SF shares binding sites with antagonists on GABAA receptors. Collectively, WP-SF effectively increased sleep duration by enhancing delta wave activity through GABAergic activation; thus, it is suggested as a functional food-grade ingredient for promoting sleep.